SGA
CPRX

Seaport Global Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History

Seaport Global Advisors’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-45,941
Closed -$537K – 67
2023
Q3 		$537K Buy
45,941
+28,592
+165% +$382K 1.61% 20
2023
Q2 		$233K Buy
17,349
+1,751
+11% +$25.2K 0.69% 52
2023
Q1 		$259K Sell
15,598
-5,257
-25% -$86.7K 0.82% 42
2022
Q4 		$388K Buy
+20,855
New +$321K 1.35% 22

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Seaport Global Advisors's CPRX Position: Q4 2023 in Review

Seaport Global Advisors sold out of Catalyst Pharmaceutical (CPRX) in Q4 2023, closing a stake of 45,941 shares — an estimated $537K sold.

Seaport Global Advisors first reported a position in CPRX in Q4 2022 and held it in 4 quarters. The position peaked at $537K in Q3 2023. 259 funds tracked by Wall St. Rank hold CPRX as of Q4 2023.

  • Seaport Global Advisors reported no remaining Catalyst Pharmaceutical position as of Q4 2023 after selling out during the quarter.
  • Seaport Global Advisors sold 45,941 Catalyst Pharmaceutical shares in Q4 2023, an estimated $537K.
  • Seaport Global Advisors first reported a position in Catalyst Pharmaceutical in Q4 2022 and held it in 4 quarters.
  • Seaport Global Advisors's Catalyst Pharmaceutical position peaked at $537K in Q3 2023.
  • 259 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q4 2023.

Based on Seaport Global Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.